Severe irritability associated with statin cholesterol-lowering drugs

被引:62
作者
Golomb, BA
Kane, T
Dimsdale, JE
机构
[1] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA
关键词
D O I
10.1093/qjmed/hch035
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: As use of a drug becomes widespread, the full spectrum of its effects becomes clearer. Although a link has been suggested between low or lowered cholesterol and irritability/aggression, less is known about possible links between irritability and statins. Aim: To assess the possible connection of statin usage to severe irritability. Design: Case series. Methods: Six patients referred or self-referred with irritability and short temper on statin cholesterol-lowering drugs completed a survey providing information on character of behavioural effect, time-course of onset and recovery, and factors relevant to drug adverse effect causality. Results: In each case the personality disruption, once evident, was sustained until statin use was discontinued; and resolved promptly with drug cessation. In four patients, re-challenge with statins occurred, and led to recrudescence of the problem. All patients experienced other recognized statin adverse effects while on the drug. Manifestations of severe irritability included homicidal impulses, threats to others, road rage, generation of fear in family members, and damage to property. Discussion: Case series invariably raise more questions than they can answer. These case reports suggest that severe irritability may occur in some statin users. Although this adverse effect may be rare, potentially life-threatening adverse effects of drugs must be taken seriously.
引用
收藏
页码:229 / 235
页数:7
相关论文
共 51 条
[1]   LOVASTATIN AND PERIPHERAL NEUROPATHY [J].
AHMAD, S .
AMERICAN HEART JOURNAL, 1995, 130 (06) :1321-1321
[2]   Effects of hypocholesterolemic dietary and drug therapy on measures of dysphoric emotions [J].
Beigel, Y ;
Peleg, A ;
Assali, A ;
Nachshon, I .
EUROPEAN PSYCHIATRY, 1998, 13 (06) :288-294
[3]  
BROWN GL, 1990, J CLIN PSYCHIAT, V51, P31
[4]   AGGRESSION IN HUMANS CORRELATES WITH CEREBROSPINAL-FLUID AMINE METABOLITES [J].
BROWN, GL ;
GOODWIN, FK ;
BALLENGER, JC ;
GOYER, PF ;
MAJOR, LF .
PSYCHIATRY RESEARCH, 1979, 1 (02) :131-139
[5]  
Buajordet Ingebjorg, 1997, Tidsskrift for den Norske Laegeforening, V117, P3210
[6]  
Duits N, 1993, Ned Tijdschr Geneeskd, V137, P1312
[7]  
EICHELMAN BS, 1973, BIOL PSYCHIAT, V6, P143
[8]   MUSCLE SIDE-EFFECTS ASSOCIATED WITH SIMVASTATIN THERAPY [J].
ENGLAND, JDF ;
VILES, A ;
WALSH, JC ;
STEWART, PM .
MEDICAL JOURNAL OF AUSTRALIA, 1990, 153 (09) :562-563
[9]   MITOCHONDRIAL MYOPATHY DEVELOPING ON TREATMENT WITH THE HMG COA REDUCTASE INHIBITORS - SIMVASTATIN AND PRAVASTATIN [J].
ENGLAND, JDF ;
WALSH, JC ;
STEWART, P ;
BOYD, I ;
ROHAN, A ;
HALMAGYI, GM .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1995, 25 (04) :374-375
[10]   HMG CoA reductase inhibitor-induced myotoxicity: Pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture [J].
Flint, OP ;
Masters, BA ;
Gregg, RE ;
Durham, SK .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 145 (01) :99-110